Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Net Margin (2024 - 2025)

Historic Net Margin for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to 357.19%.

  • Kura Oncology's Net Margin fell 135620400.0% to 357.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 431.95%, marking a year-over-year change of. This contributed to the annual value of 322.89% for FY2024, which is 101764100.0% down from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Net Margin is 357.19%, which was down 135620400.0% from 432.51% recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Net Margin peaked at 13204.85% during Q3 2024, and registered a low of 432.51% during Q2 2025.